Policy Notices

• Notice to Extend PA-20-074 "Disseminating and Implementing Patient-Centered Outcomes Research (PCOR) Evidence into Practice through Interoperable Clinical Decision Support (R18)"
  (NOT-HS-22-022)
  Agency for Healthcare Research and Quality
  

General Notices

• Notice of Clarification of Research Examples for PAR-20-266: Promoting Research on Music and Health: Phased Innovation Award for Music Interventions (R61/R33 Clinical Trial Optional)
  (NOT-AT-22-028)
  National Center for Complementary and Integrative Health
  

• Notice of Extension of PAR-21-206, Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional)
  (NOT-CA-22-099)
  National Cancer Institute
  

• Notice of Correction to RFA-CA-22-045, NCI Outstanding Investigator Award (R35 Clinical Trial Optional)
  (NOT-CA-22-117)
  National Cancer Institute
  

• Notice of Change in Receipt Date for Applications to Harnessing Technologies to Support Oral Health Promotion and Management Outside the Dental Setting (RFA-DE-23-009)
  (NOT-DE-22-012)
  National Institute of Dental and Craniofacial Research
  

• Notice of Pre-Application Webinar for RFA-DK-22-014 and RFA-DK-22-015, Interventions that Address Structural Racism to Reduce Kidney Health Disparities (U01- Clinical Trial Required and U24 - Clinical Trial Not Allowed)
  (NOT-DK-22-024)
  National Institute of Diabetes and Digestive and Kidney Diseases
  

• Notice of Informational Webinar on the NIH Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Program Funding Opportunity Announcements (K99/R00 and UE5)
  (NOT-GM-22-044)
  National Institute of General Medical Sciences
  

• Notice of Pre-Application and Technical Assistance Webinar for RFA-MH-22-240, "BRAIN Initiative: Brain Behavior Quantification and Synchronization (R61/R33 Clinical Trial Optional)"
  (NOT-MH-22-290)
  National Institute of Mental Health
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Neurological Disorders and Stroke
  

• Findings of Research Misconduct
  (NOT-OD-22-199)
  Office of the Director, NIH
  

• Free NIH Virtual Events for Early Career Scientists in August and September - Register Today!
  (NOT-OD-22-200)
  National Institutes of Health
  

• Technical and Business Assistance (TABA) Consulting Services for National Institutes of Health (NIH) Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Awardees
  (NOT-OD-22-201)
  Office of the Director, NIH
  

• Notice of Information: Upcoming Research Opportunity Announcement (ROA) for Community Partnerships to Advance Science for Society (ComPASS) Program: Community-Led, Health Equity Structural Intervention Initiative (CHESI) (OT2 Clinical Trial Optional)
  (NOT-RM-23-001)
  Office of Strategic Coordination (Common Fund)
  

Notice of Changes to Funding Opportunities

• Notice of Correction to the Subaward Budget Amount for RFA-AG-23-027, Resource Centers for Minority Aging Research (RCMAR) Coordinating Center (U24 Clinical Trial Optional)
  (NOT-AG-22-027)
  National Institute on Aging
  

• Notice Regarding TPG Revision Applications and New Applications for RFA-OH-22-003: "Occupational Safety and Health Training Project Grants (T03)"
  (NOT-OH-22-006)
  National Institute for Occupational Safety and Health
  

Notices of Intent to Publish

• Notice of Intent to Publish a Funding Opportunity Announcement for Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Centers (U54 Clinical Trial Not Allowed)
  (NOT-CA-22-120)
  National Cancer Institute
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Community Partnerships to Advance Science for Society (ComPASS): Coordination Center (U24 - Clinical Trial Optional)
  (NOT-RM-23-002)
  Office of Strategic Coordination (Common Fund)
  

Funding Opportunities

• AHRQ Conference Grant Programs (R13)
  (PA-22-238)
  Agency for Healthcare Research and Quality
  Application Receipt Date(s): October 31, 2026
  
  

• Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (U01 Clinical Trial Optional)
  (PAR-22-228)
  National Institute on Aging
  Application Receipt Date(s): February 21, 2023
  
  

• Laboratory of Developmental Biology (R24 Clinical Trial Not Allowed)
  (PAR-22-229)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Allergy and Infectious Diseases
  National Institute of Mental Health
  Application Receipt Date(s): November 02, 2022
  
  

• Javits Neuroscience Investigator Award Extension Request (Type 4 Clinical Trial Optional)
  (PAR-23-022)
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): The earliest Application Due Date is September 15, 2022 NINDS Javits award Phase 2 requests are due sixty days prior to the end of the initial phase budget period. Recipients are encouraged to contact the NINDS program director and grants management specialist assigned to the R37 award for details. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  
  

• Fostering Mental, Emotional, and Behavioral (MEB) Health Among Children in School Settings: Opportunities for Multisite Trials of Complementary and Integrative Health Interventions (Clinical Trial Optional)
  (RFA-AT-23-003)
  National Center for Complementary and Integrative Health
  Office of Disease Prevention
  Application Receipt Date(s): October 28, 2022
  
  

• Research Resource Center to Build an Open-Access Repository and Database for Anatomical and Physiological Correlates of Acupoints (U24, Clinical Trial Optional)
  (RFA-AT-23-005)
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): November 30, 2022
  
  

• Consortium on Translational Research in Early Detection of Liver Cancer: Translational Research Centers (U01 Clinical Trial Optional)
  (RFA-CA-22-031)
  National Cancer Institute
  Application Receipt Date(s): November 07, 2022
  
  

• Consortium on Translational Research in Early Detection of Liver Cancer: Data Management and Coordinating Center (U24 Clinical Trial Not Allowed)
  (RFA-CA-22-032)
  National Cancer Institute
  Application Receipt Date(s): November 07, 2022
  
  

• The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Clinical Trial Not Allowed)
  (RFA-CA-22-041)
  National Cancer Institute
  Application Receipt Date(s): November 18, 2022
  
  

• Radiation Oncology-Biology Integration Network (ROBIN) Centers (U54 Clinical Trial Required)
  (RFA-CA-22-046)
  National Cancer Institute
  Application Receipt Date(s): October 03, 2022
  
  

• The Early Detection Research Network: Clinical Validation Centers (U01 Clinical Trial Optional)
  (RFA-CA-22-054)
  National Cancer Institute
  Application Receipt Date(s): September 19, 2022
  
  

• HEAL Initiative: Development and validation of virtual assessments to study children and caregivers in their natural environment (R01- Clinical Trial Not Allowed)
  (RFA-DA-23-050)
  National Institute on Drug Abuse
  National Center for Complementary and Integrative Health
  National Institute on Alcohol Abuse and Alcoholism
  Application Receipt Date(s): February 03, 2023
  
  

• HEAL Initiative: Development and validation of virtual assessments to study children and caregivers in their natural environment (R01- Basic Experimental Studies with Humans Required)
  (RFA-DA-23-055)
  National Institute on Drug Abuse
  National Center for Complementary and Integrative Health
  National Institute on Alcohol Abuse and Alcoholism
  Application Receipt Date(s): February 07, 2023
  
  

• Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)
  (RFA-DA-23-056)
  National Institute on Drug Abuse
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): November 19, 2024
  
  

• Practice-Based Research Integrating Multidisciplinary Experiences in Dental Schools (PRIMED) (U01 Clinical Trial Not Allowed)
  (RFA-DE-23-012)
  National Institute of Dental and Craniofacial Research
  Application Receipt Date(s): February 24, 2023
  
  

• MPRINT Translational Research Resource Platform (TRRP) (U24 Clinical Trial Not Allowed)
  (RFA-HD-23-018)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): December 01, 2022
  
  

• Training Award to Promote Cross-Training in the Fields of Traumatic Brain Injury (TBI) as a Risk Factor for Alzheimers Disease/Alzheimers Disease Related Dementias (AD/ADRD) (K18 Clinical Trial Not Allowed)
  (RFA-NS-22-061)
  National Institute of Neurological Disorders and Stroke
  National Institute on Aging
  Application Receipt Date(s): November 04, 2022